← All patents

US20220160678A1

Modulation of molecular markers using s-equol

University of Texas System

Abstract

The present invention provides methods and compositions for modulating molecular markers, and hence treating or preventing breast cancer (e.g., triple-negative breast cancer) and melanoma with a pharmaceutically effective amount of S-equol or a pharmaceutical composition comprising S-equol. The S- …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Rong Li
Priority date
November 24, 2020
Filing date
November 24, 2021
Publication date
May 26, 2022
Language
en
Metadata fetched
August 29, 2026 00:30